COVID-19 and liver disease: mechanistic and clinical perspectives
Thomas Marjot(Oxford Centre for Diabetes, Endocrinology and Metabolism), Eleanor Barnes(Oxford Health NHS Foundation Trust), Gwilym J. Webb(University of Cambridge), Zania Stamataki(University of Birmingham), Vincent Wai‐Sun Wong(Chinese University of Hong Kong), A. Sidney Barritt(University of North Carolina at Chapel Hill), Andrew M. Moon(University of North Carolina at Chapel Hill)
Cited by 392
Related Papers
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018
|Gastroenterology|2018|1.7k